/
We are a manufacturer and distributor of supplements in categories such as pain, energy, prenatal, general health, bone and joint, gastro, immunity, cardiac, detox, mental clarity & focus, sleep, prenatal and urinary. Our end markets focus on end-consumers through different channels that include pharmacies, US wholesalers, international distributors and direct-to-consumers sales.
The business is unprofitable at the operating level (-21.15% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue growth slowed to 0.7%, essentially flat. Margins also contracted 17.7pp. This is a business that needs a catalyst.
Free cash flow declined 1174464% versus the prior year, cash generation momentum has weakened. ROIC dropped from -8.09% to -37.58%, capital efficiency is deteriorating.
Profitability & Returns
Revenue (TTM)
$7M
▲ +0.7% YoY
Net Income (TTM)
-$6M
▲ +235.6% YoY
Op. Margin
-27.15%
▼ -17.7pp YoY
ROIC
-60.55%
▼ -29.5pp YoY
Cash Flow & Balance Sheet
FCF (FY)
-$1M
▼ -1174464.2% YoY
Op. Cash Flow (FY)
-$1M
▼ -63996.7% YoY
Net Debt
$777K
Cash & Equiv.
$1M
Continue Research